How much revenue did Centogene generate this year?
Centogene has achieved a revenue of 60.69 M EUR this year.
Centogene Revenue 2024
Centogene Revenue
60.69 M EUR
Ticker
CNTG
ISIN
NL0014040206
WKN
A2PUCU
In 2024, Centogene's sales reached 60.69 M EUR, a 25.04% difference from the 48.54 M EUR sales recorded in the previous year.
The Centogene Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2025e | 29.27 | 60,44 |
| 2024e | 60.69 | 29,16 |
| 2023 | 48.54 | 36,46 |
| 2022 | 47.47 | 41,96 |
| 2021 | 42.23 | 34,50 |
| 2020 | 38.45 | 20,47 |
| 2019 | 48.78 | 46,70 |
| 2018 | 40.48 | 50,74 |
| 2017 | 31.69 | 52,86 |
| 2016 | 27.67 | 53,52 |
Centogene Revenue, EBIT, Net Income NL0014040206 · A2PUCU
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Centogene, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Centogene from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Centogene’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Centogene. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Centogene’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Centogene’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Centogene’s growth potential.
Centogene Revenue, EBIT and net profit per share
| Date | Centogene Revenue | Centogene EBIT | Centogene Net Income |
|---|---|---|---|
| 2025e | 29.27 M undefined | -44.56 M undefined | -54.33 M undefined |
| 2024e | 60.69 M undefined | -40.39 M undefined | -27.31 M undefined |
| 2023 | 48.54 M undefined | -28.03 M undefined | -35.53 M undefined |
| 2022 | 47.47 M undefined | -35.92 M undefined | -31.84 M undefined |
| 2021 | 42.23 M undefined | -54.65 M undefined | -46.25 M undefined |
| 2020 | 38.45 M undefined | -50.1 M undefined | -21.99 M undefined |
| 2019 | 48.78 M undefined | -18.13 M undefined | -20.86 M undefined |
| 2018 | 40.48 M undefined | -10.51 M undefined | -11.34 M undefined |
| 2017 | 31.69 M undefined | -4.54 M undefined | -5.48 M undefined |
| 2016 | 27.67 M undefined | -5.03 M undefined | -5.36 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2016 | 27.67 M EUR | -5.03 M EUR | -5.36 M EUR |
| 2017 | 31.69 M EUR | -4.54 M EUR | -5.48 M EUR |
| 2018 | 40.48 M EUR | -10.51 M EUR | -11.34 M EUR |
| 2019 | 48.78 M EUR | -18.13 M EUR | -20.86 M EUR |
| 2020 | 38.45 M EUR | -50.1 M EUR | -21.99 M EUR |
| 2021 | 42.23 M EUR | -54.65 M EUR | -46.25 M EUR |
| 2022 | 47.47 M EUR | -35.92 M EUR | -31.84 M EUR |
| 2023 | 48.54 M EUR | -28.03 M EUR | -35.53 M EUR |
| 2024e | 60.69 M EUR | -40.39 M EUR | -27.31 M EUR |
| 2025e | 29.27 M EUR | -44.56 M EUR | -54.33 M EUR |
Centogene stock margins NL0014040206 · A2PUCU
The Centogene margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Centogene. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Centogene.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Centogene's sales revenue. A higher gross margin percentage indicates that the Centogene retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Centogene's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Centogene's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Centogene's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Centogene. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Centogene's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Centogene Margin History
| Centogene Gross margin | Centogene Profit margin | Centogene EBIT margin | Centogene Profit margin |
|---|---|---|---|
| 2025e | 36.46 % | -152.23 % | -185.59 % |
| 2024e | 36.46 % | -66.55 % | -44.99 % |
| 2023 | 36.46 % | -57.74 % | -73.21 % |
| 2022 | 41.96 % | -75.67 % | -67.07 % |
| 2021 | 34.5 % | -129.41 % | -109.52 % |
| 2020 | 20.47 % | -130.3 % | -57.19 % |
| 2019 | 46.7 % | -37.17 % | -42.76 % |
| 2018 | 50.74 % | -25.96 % | -28.01 % |
| 2017 | 52.86 % | -14.33 % | -17.29 % |
| 2016 | 53.52 % | -18.18 % | -19.37 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2016 | 53.52 % | -18.18 % | -19.37 % |
| 2017 | 52.86 % | -14.33 % | -17.29 % |
| 2018 | 50.74 % | -25.96 % | -28.01 % |
| 2019 | 46.7 % | -37.17 % | -42.76 % |
| 2020 | 20.47 % | -130.3 % | -57.19 % |
| 2021 | 34.5 % | -129.41 % | -109.52 % |
| 2022 | 41.96 % | -75.67 % | -67.07 % |
| 2023 | 36.46 % | -57.74 % | -73.21 % |
| 2024e | 36.46 % | -66.55 % | -44.99 % |
| 2025e | 36.46 % | -152.23 % | -185.59 % |
Centogene Aktienanalyse
What does Centogene do?
Centogene NV is a biotechnology company specializing in the research and diagnosis of rare genetic diseases. It was founded in 2006 by Arndt Rolfs and Christoph Lengauer in Rostock. The business model of Centogene NV is based on the application of genomic research and advanced technologies to develop novel diagnostic and therapeutic approaches. The company operates its own laboratories where DNA samples are analyzed and evaluated. The goal is to identify the genetic causes of rare diseases and provide patients with personalized treatment options. The company operates in several areas. One focus is on the diagnosis of rare diseases that have unclear genetic causes. The company offers a wide range of genetic tests that aim to enable fast and precise diagnosis. These include exome sequencing, RNA analysis, and gene panel tests. Another business field of Centogene NV is the development of new therapy approaches for rare diseases. The company collaborates with pharmaceutical companies and clinical researchers to develop innovative drugs and conduct clinical trials. The aim is to offer improved treatment options and enhance the quality of life for patients with rare diseases. Centogene NV is headquartered in Rostock, Germany, but also has offices in Lisbon, Portugal, Dubai, United Arab Emirates, and Boston, USA. The company operates globally and collaborates with medical centers and research laboratories worldwide. A special feature of Centogene NV is the CentoMD® database system. This is an extensive genetic database that contains clinical and genetic information from patients with rare diseases. This database is a valuable resource for diagnosis, research, and the development of new therapy approaches. The company works closely with patient groups and international organizations to raise awareness of rare diseases and create better treatment options. Centogene NV is also involved in the education and training of medical professionals to ensure better care for patients. Overall, Centogene NV is a leading company in the research and diagnosis of rare genetic diseases. The business model is based on the application of cutting-edge genomic research and technologies to provide patients with personalized treatment options. The company operates globally and has its own laboratories and extensive genetic database. Centogene NV is actively involved in research and education to improve the care of patients with rare diseases. Centogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Centogene's Sales Figures
The sales figures of Centogene originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Centogene’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Centogene's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Centogene’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Centogene stock
How much was the turnover of the company Centogene compared to the previous year?
The revenue of Centogene has increased by 25.04% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Centogene?
The revenue of Centogene is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Centogene measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Centogene so important for investors?
The revenue of Centogene is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Centogene pay?
Over the past 12 months, Centogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Centogene is expected to pay a dividend of 0 EUR.
What is the dividend yield of Centogene?
The current dividend yield of Centogene is .
When does Centogene pay dividends?
Centogene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Centogene?
Centogene paid dividends every year for the past 0 years.
What is the dividend of Centogene?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Centogene located?
Centogene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Centogene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Centogene from 7/4/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.
When did Centogene pay the last dividend?
The last dividend was paid out on 7/4/2024.
What was the dividend of Centogene in the year 2023?
In the year 2023, Centogene distributed 0 EUR as dividends.
In which currency does Centogene pay out the dividend?
The dividends of Centogene are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Centogene stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Centogene
Our stock analysis for Centogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Centogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
